Samsrita Labs Limited appointed Mr. Satyanarayana Murthy Varanasi as an Additional Director in the Independent category for a term of five years effective July 4, 2026, subject to shareholder approval. The board also approved a scheme to reduce its issued, subscribed, and paid-up share capital by ₹11.37 crore to set off accumulated losses and reorganize its equity structure. These decisions were taken during a board meeting held on July 4, 2026, at the company's registered office in Hyderabad.

The proposed capital reduction involves the cancellation and extinguishment of 11,37,48,550 fully paid-up equity shares of ₹10 each on a pro-rata basis. This move aims to realign the capital base to better reflect the company's current financial position. The reduction will decrease the paid-up equity share capital from ₹22.74 crore, comprising 2,27,49,710 equity shares, to ₹11.37 crore, comprising 1,13,74,855 equity shares.

As a consequence of the cancellation, the company proposes to set off ₹11.37 crore out of the total accumulated losses and share premium balance totaling ₹11.57 crore. This action will result in a significant reduction of accumulated losses and the cancellation of the entire share premium amount lying in the company's balance sheet. The board believes this step is necessary to present a true and fair view of the financial position.

The scheme is subject to approval from shareholders and the Hyderabad Bench of the National Company Law Tribunal (NCLT). BSE Limited has been nominated as the Designated Stock Exchange for the purpose of the scheme. The relative shareholding percentages of all continuing shareholders will remain unchanged, and no consideration will be paid for the cancelled shares.

Board Appointments and Approvals

The board appointed Mr. Satyanarayana Murthy Varanasi (DIN: 11121911) as an Additional Director. He holds 1,14,430 equity shares, representing a 0.50% stake in the company. Mr. Varanasi possesses rich experience in defence, aviation, maritime operations, legal practice, and management consulting, having served in the Indian Navy, Indian Airlines, and Visakhapatnam Port Trust. He is presently practicing as an Advocate before the High Court of Telangana.

Additionally, the board appointed Mr. Ravi Kanth Naga Pattabhi Chopperla (DIN: 06812649) as an Additional Director in the category of Professional and Non-Executive. He holds 16,16,001 equity shares, representing a 7.1% stake in the company. Mr. Chopperla is a seasoned business leader with over 18 years of experience in investor relations and corporate advisory, currently serving as Executive Director & Chief Operating Officer of QROPS Advisory Services Private Limited.

The board also approved the alteration of the Main Object Clause of the Memorandum of Association to include the business of pet animal healthcare and wellness. This expansion covers veterinary services, pharmaceuticals, and related products. The company also proposed entering into related party transactions with QROPS Advisory Services Private Limited, an associate company, subject to shareholder approval.

Financial Meeting Schedule

The Annual General Meeting (AGM) for the financial year 2025-26 is scheduled to be held on August 10, 2026, at 11:00 A.M. via video conference. The cut-off date for determining shareholder eligibility for the AGM is August 3, 2026. The Directors' Report for the financial year 2025-26 was also approved by the board.

Samsrita Labs Limited will hold a board meeting on July 4, 2026, to consider a draft Scheme of Reorganization and the rearrangement of share capital. The meeting is scheduled to take place at the company's registered office in Hyderabad. The board will also discuss any other business with the permission of the Chair.

In compliance with Regulation 9 of the SEBI (Prohibition of Insider Trading) Regulations, 2015, the trading window for dealing in the company's securities has been closed since June 30, 2026. This closure applies to all connected persons, officers, designated employees, insiders, directors, and their immediate relatives. The window will remain shut until 48 hours after the conclusion of the board meeting.

Additionally, the company stated that the trading window will continue to stay closed until 48 hours after the declaration of the unaudited financial results for the quarter ended June 30, 2026. This measure is part of the company's Code of Conduct for Prevention of Insider Trading, which is framed in accordance with SEBI regulations.

The intimation was signed by K.N.V. Narendra Kumar, Whole-time Director & CFO of Samsrita Labs Limited. The company is listed on BSE Limited and Metropolitan Stock Exchange of India Limited with scrip code 539267 and symbol SAMSRITA, respectively.

Key Meeting Details